Tags

Type your tag names separated by a space and hit enter

Movement disorders associated with aripiprazole use: a case series.
Int J Neurosci. 2009; 119(12):2274-9.IJ

Abstract

Aripiprazole is an atypical antipsychotic that is a partial agonist at the D2 and 5HT1a receptors and an antagonist at 5HT2a receptors. Despite previous hypotheses that it would be less likely to cause movement disorders, recent reports suggest it actually may be more likely to cause movement disorders than other atypical antipsychotics. This case series illustrates the variety of movement disorders associated with aripiprazole use at three movement disorder clinics. It also suggests that aripiprazole be used with caution in patients with a prior history of dystonia, parkinsonism, or previous tardive dyskinesia.

Authors+Show Affiliations

Rush University, Chicago, Illinois, USA. Deborah A Hall@rush.eduNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

19916856

Citation

Hall, Deborah A., et al. "Movement Disorders Associated With Aripiprazole Use: a Case Series." The International Journal of Neuroscience, vol. 119, no. 12, 2009, pp. 2274-9.
Hall DA, Agarwal P, Griffith A, et al. Movement disorders associated with aripiprazole use: a case series. Int J Neurosci. 2009;119(12):2274-9.
Hall, D. A., Agarwal, P., Griffith, A., Segro, V., & Seeberger, L. C. (2009). Movement disorders associated with aripiprazole use: a case series. The International Journal of Neuroscience, 119(12), 2274-9. https://doi.org/10.3109/00207450903225553
Hall DA, et al. Movement Disorders Associated With Aripiprazole Use: a Case Series. Int J Neurosci. 2009;119(12):2274-9. PubMed PMID: 19916856.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Movement disorders associated with aripiprazole use: a case series. AU - Hall,Deborah A, AU - Agarwal,Pinky, AU - Griffith,Alida, AU - Segro,Vicki, AU - Seeberger,Lauren C, PY - 2009/11/18/entrez PY - 2009/11/18/pubmed PY - 2010/1/29/medline SP - 2274 EP - 9 JF - The International journal of neuroscience JO - Int. J. Neurosci. VL - 119 IS - 12 N2 - Aripiprazole is an atypical antipsychotic that is a partial agonist at the D2 and 5HT1a receptors and an antagonist at 5HT2a receptors. Despite previous hypotheses that it would be less likely to cause movement disorders, recent reports suggest it actually may be more likely to cause movement disorders than other atypical antipsychotics. This case series illustrates the variety of movement disorders associated with aripiprazole use at three movement disorder clinics. It also suggests that aripiprazole be used with caution in patients with a prior history of dystonia, parkinsonism, or previous tardive dyskinesia. SN - 1563-5279 UR - https://www.unboundmedicine.com/medline/citation/19916856/Movement_disorders_associated_with_aripiprazole_use:_a_case_series_ L2 - http://www.tandfonline.com/doi/full/10.3109/00207450903225553 DB - PRIME DP - Unbound Medicine ER -